Candidate metabolites selected in each group (alpha tocopherol for AA and EA combined, valine for AA and glycine for EA) show better performance than AFP only, and the combination with AFP, in distinguishing HCC cases from cirrhotic controls. The gene discussed is AFP; the disease is hepatocellular carcinoma.